康臣药业(01681)10月31日斥资525.9万港元回购35万股
Core Viewpoint - 康臣药业 announced a share buyback plan, intending to repurchase 350,000 shares at a cost of HKD 5.259 million by October 31, 2025 [1] Company Summary - 康臣药业 plans to spend HKD 5.259 million for the repurchase of 350,000 shares [1]